Boston.com THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
LIFE SCIENCES

Life Sciences 25

Boston Scientific recalled a small number of implantable defibrillators; Biogen said a one-year study showed its multiple sclerosis drug was more cost-effective than other treatments.

LAST MARKET CAP LAST PCT.
NO. WEEK COMPANY TICKER (MILLIONS) PRICE CHANGE
1 1 Boston Scientific Corp. BSX $22,249 $15.01 0.3%
2 2 Thermo Fisher Scientific TMO $20,569 $48.97 0.7%
3 3 Genzyme Corp. GENZ $16,476 $62.54 1.6%
4 4 Biogen Idec BIIB $15,605 $45.57 1.2%
5 5 Waters Corp. WAT $6,096 $60.04 -0.2%
6 6 Sepracor SEPR $5,590 $50.74 3.4%
7 7 Cytyc Corp. CYTC $3,957 $34.47 -0.9%
8 8 Millipore Corp. MIL $3,949 $73.21 -0.7%
9 9 Vertex Pharmaceuticals VRTX $3,820 $30.16 -2.5%
10 10 Millennium Pharmaceuticals MLNM $3,679 $11.58 0.0%
11 12 Charles River Laboratories CRL $3,221 $48.12 3.6%
12 11 Hologic HOLX $3,169 $59.53 -0.7%
13 13 PerkinElmer PKI $3,063 $25.14 1.9%
*14 83 Inverness Medical Innovations IMA $1,850 $40.00 -4.4%
15 14 Alkermes ALKS $1,562 $15.47 -2.1%
16 15 Cubist Pharmaceuticals CBST $1,279 $23.19 1.0%
17 16 Haemonetics Corp. HAE $1,226 $46.42 -1.6%
18 17 Bruker BioSciences Corp. BRKR $1,163 $11.05 4.3%
19 20 Advanced Magnetics AMAG $1,007 $71.19 9.2%
20 18 Parexel International Corp. PRXL $1,003 $36.69 -0.9%
21 19 PolyMedica Corp. PLMD $930 $41.14 -3.4%
22 22 Alnylam Pharmaceuticals ALNY $720 $19.45 8.8%
23 21 Palomar Medical Technologies PMTI $712 $39.19 3.7%
24 23 Zoll Medical Corp. ZOLL $525 $26.25 1.4%
25 25 Momenta Pharmaceuticals MNTA $522 $14.38 6.5%

The Boston Globe/Bloomberg Massachusetts Technology and Life Sciences indexes are price-weighted indexes of all technology and life sciences stocks in the state. Listed above are the top companies, ranked by market value, in each sector. Asterisks indicate a stock that has moved five places or more in the last week. For up-to-the-minute rankings and stock prices, visit boston.com/business

© Copyright The New York Times Company